ICER's assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33119438.
- Also identified by DOI 10.18553/jmcp.2020.26.11.1464 and PMC identifier 10390931.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>DISCLOSURES:</b> No funding supported the writing of this commentary. The authors have nothing to disclose.
Medical subject headings
- Migraine Disorders
- Pyridines